Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
作者信息
Alberto P
出版信息
Cancer Chemother Rep 3. 1973 Mar;4(2):199-206.
PMID:4729321
Abstract
摘要
相似文献
1
Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
Cancer Chemother Rep 3. 1973 Mar;4(2):199-206.
2
[Prognostic factors in the chemotherapy of bronchial cancers].[支气管癌化疗中的预后因素]
Schweiz Med Wochenschr. 1974 Feb 23;104(8):268-71.
3
Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.肺癌小细胞癌的联合化疗与放射治疗
Cancer Chemother Rep 3. 1973 Mar;4(2):171-6.
4
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Schweiz Med Wochenschr. 1977 Jul 2;107(26):912-5.
5
Chemotherapy in bronchogenic carcinoma.
Ann Clin Res. 1977 Feb;9(1):12-4.
6
7
Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.采用包括甲氨蝶呤、环磷酰胺、丙卡巴肼和长春新碱的同步或序贯联合化疗方案治疗支气管源性癌。
Cancer. 1976 Dec;38(6):2208-16. doi: 10.1002/1097-0142(197612)38:6<2208::aid-cncr2820380603>3.0.co;2-h.
8
[Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Prax Klin Pneumol. 1980 Dec;34(12):719-23.
9
[Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].[癌症化疗作为支气管癌手术的辅助治疗]
Ugeskr Laeger. 1976 Jun 7;138(24):1449-55.
10
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
JAMA. 1978 Dec 15;240(25):2743-6.
引用本文的文献
1
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.一项关于支气管癌术后化疗研究中所有患者的15年随访。
Br J Cancer. 1985 Dec;52(6):867-73. doi: 10.1038/bjc.1985.271.
2
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma.阿霉素对晚期肺癌体外作用的临床相关性
Klin Wochenschr. 1976 Jul 15;54(14):665-70. doi: 10.1007/BF01469146.
3
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.细胞毒性化疗作为支气管癌手术辅助治疗的5年随访
Br J Cancer. 1976 Aug;34(2):167-73. doi: 10.1038/bjc.1976.139.
Zotero 插件